[1]
|
Kawasaki, T. (1967) Acute Febrile Mucocutaneous Syndrome with Lymphoid Involvement with Specific Desquamation of the Fingers and Toes in Children. Arerugi, 16, 178-222.
|
[2]
|
Nakamura, Y. (2018) Kawasaki Disease: Epidemiology and the Lessons from It. The International Journal of Rheumatic Diseases, 21, 16-19. https://doi.org/10.1111/1756-185X.13211
|
[3]
|
Uehara, R. and Belay, E.D. (2012) Epidemiology of Kawasaki Disease in Asia, Europe, and the United States. Journal of Epidemiology, 22, 79-85. https://doi.org/10.2188/jea.JE20110131
|
[4]
|
Medeiros, R.d.M.C., Coutinho de Almeida, F., Gandolfi, L., et al. (2020) Clinical Manifestations of Kawasaki Disease at Different Age Spectrum: A Ten-Year Study. Medicina (Kaunas), 56, 145.
|
[5]
|
Heaton, P., Wilson, N., Nicholson, R., et al. (2006) Kawasaki Disease in New Zealand. Journal of Paedi-atrics and Child Health, 42, 184-190. https://doi.org/10.1111/j.1440-1754.2006.00827.x
|
[6]
|
Saundankar, J., Yim, D., Itotoh, B., et al. (2014) The Epidemiology and Clinical Features of Kawasaki Disease in Australia. Pediatrics, 133, e1009-e1014. https://doi.org/10.1542/peds.2013-2936
|
[7]
|
Mabiala Babela, J.R., Ollandzobo Ikobo, L.C., Nika, R.E., et al. (2015) Study of 11 New Cases of Kawasaki Disease Congolese. Bulletin de la Société de Pathologie Exotique, 108, 250-254. https://doi.org/10.1007/s13149-015-0445-2
|
[8]
|
Bar-Meir, M., Haklai, Z. and Dor, M. (2011) Ka-wasaki Disease in Israel. The Pediatric Infectious Disease Journal, 30, 589-592. https://doi.org/10.1097/INF.0b013e31820e3849
|
[9]
|
Callinan, L.S., Tabnak, F., Holman, R.C., et al. (2012) Ka-wasaki Syndrome and Factors Associated with Coronary Artery Abnormalities in California. The Pediatric Infectious Disease Journal, 31, 894-898.
https://doi.org/10.1097/INF.0b013e31825c4d7c
|
[10]
|
Newburger, J.W., Takahashi, M., Gerber, M.A., et al. (2004) Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics, 114, 1708-1733. https://doi.org/10.1542/peds.2004-2182
|
[11]
|
Holve, T.J., Patel, A., Chau, Q., et al. (2014) Long-Term Cardiovascular Outcomes in Survivors of Kawasaki Disease. Pediatrics, 133, e305-e311. https://doi.org/10.1542/peds.2013-1638
|
[12]
|
Daniels, L.B., Tjajadi, M.S., Walford, H.H., et al. (2012) Prevalence of Kawasaki Disease in Young Adults with Suspected Myocardial Ischemia. Circulation, 125, 2447-2453. https://doi.org/10.1161/CIRCULATIONAHA.111.082107
|
[13]
|
Tsuda, E., Hamaoka, K., Suzuki, H., et al. (2014) A Survey of the 3-Decade Outcome for Patients with Giant Aneurysms Caused by Kawasaki Disease. American Heart Journal, 167, 249-258. https://doi.org/10.1016/j.ahj.2013.10.025
|
[14]
|
McCrindle, B.W., Rowley, A.H., Newburger, J.W., et al. (2017) Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scien-tific Statement for Health Professionals from the American Heart Association. Circulation, 135, e927-e999.
|
[15]
|
Xie, L.P., Yan, W.L., Huang, M., et al. (2020) Epidemiologic Features of Kawasaki Disease in Shanghai from 2013 through 2017. Journal of Epidemiology, 30, 429-435. https://doi.org/10.2188/jea.JE20190065
|
[16]
|
Kitano, N., Suzuki, H., Takeuchi, T., et al. (2014) Epidemiologic Features and Prognostic Factors of Coronary Artery Lesions Associated with Kawasaki Disease Based on a 13-Year Cohort of Consecutive Cases Identified by Complete Enumeration Surveys in Wakayama, Japan. Journal of Epidemiology, 24, 427-434.
https://doi.org/10.2188/jea.JE20140018
|
[17]
|
Makino, N., Nakamura, Y., Yashiro, M., et al. (2015) Descriptive Epidemiology of Kawasaki Disease in Japan, 2011-2012: From the Results of the 22nd Nationwide Survey. Journal of Epidemiology, 25, 239-245.
https://doi.org/10.2188/jea.JE20140089
|
[18]
|
Makino, N., Nakamura, Y., Yashiro, M., et al. (2019) Nationwide Epidemiologic Survey of Kawasaki Disease in Japan, 2015-2016. Pediatrics International, 61, 397-403. https://doi.org/10.1111/ped.13809
|
[19]
|
Yanagawa, H., Nakamura, Y., Yashiro, M., et al. (2001) Incidence Survey of Kawasaki Disease in 1997 and 1998 in Japan. Pediatrics, 107, E33. https://doi.org/10.1542/peds.107.3.e33
|
[20]
|
Kim, G.B., Park, S., Eun, L.Y., et al. (2017) Epidemiology and Clinical Features of Kawasaki Disease in South Korea, 2012-2014. The Pediatric Infectious Disease Journal, 36, 482-485. https://doi.org/10.1097/INF.0000000000001474
|
[21]
|
Kim, G.B., Eun, L.Y., Han, J.W., et al. (2020) Epidemiology of Kawasaki Disease in South Korea: A Nationwide Survey 2015-2017. The Pediatric Infectious Disease Journal, 39, 1012-1016.
https://doi.org/10.1097/INF.0000000000002793
|
[22]
|
杜忠东, 陈笑征. 川崎病流行病学研究进展[J]. 中国实用儿科杂志, 2017, 32(8): 565-569.
https://doi.org/10.19538/j.ek2017080602
|
[23]
|
黄国英. 川崎病的流行病学特征[J]. 中国全科医学, 2007(5): 390-391.
|
[24]
|
冯亚伟, 干意, 涂丹娜. 川崎病流行病学及分子学研究进展[J]. 中国临床研究, 2022, 35(8): 1159-1163.
https://doi.org/10.13429/j.cnki.cjcr.2022.08.028
|
[25]
|
Lin, M.C., Lai, M.S., Jan, S.L., et al. (2015) Epidemiologic Features of Kawasaki Disease in Acute Stages in Taiwan, 1997-2010: Effect of Different Case Definitions in Claims Data Analysis. Journal of the Chinese Medical Association, 78, 121-126. https://doi.org/10.1016/j.jcma.2014.03.009
|
[26]
|
Ng, Y.M., Sung, R.Y., So, L.Y., et al. (2005) Kawasaki Disease in Hong Kong, 1994 to 2000. Hong Kong Medical Journal, 11, 331-335.
|
[27]
|
Du, Z.D., Zhao, D., Du, J., et al. (2007) Epidemiologic Study on Kawasaki Disease in Beijing from 2000 through 2004. The Pediatric Infectious Disease Journal, 26, 449-451. https://doi.org/10.1097/01.inf.0000261196.79223.18
|
[28]
|
董彤. 病原体感染与川崎病发病机制关系的研究进展[J]. 国际儿科学杂志, 2020, 47(1): 18-21.
https://doi.org/10.3760/cma.j.issn.1673-4408.2020.01.005
|
[29]
|
黄琴. 川崎病病原体感染作用机制及药物治疗研究进展[J]. 中外医学研究, 2022, 20(33): 171-176.
https://doi.org/10.14033/j.cnki.cfmr.2022.33.043
|
[30]
|
Brown, T.J., Crawford, S.E., Cornwall, M.L., et al. (2001) CD8 T Lymphocytes and Macrophages Infiltrate Coronary Artery Aneurysms in Acute Kawasaki Disease. The Journal of Infectious Diseases, 184, 940-943.
https://doi.org/10.1086/323155
|
[31]
|
汤昔康, 覃丽君, 范毅敏. 不完全性川崎病急性期细胞免疫和体液免疫功能分析[J]. 新医学, 2013, 44(9): 636-638.
|
[32]
|
Wang, C.L., Wu, Y.T., Liu, C.A., et al. (2003) Expression of CD40 Ligand on CD4+ T-Cells and Platelets Correlated to the Coronary Artery Lesion and Disease Progress in Kawasaki Dis-ease. Pediatrics, 111, E140-E147.
https://doi.org/10.1542/peds.111.2.e140
|
[33]
|
王国兵, 李成荣, 杨军, 等. IL-6/STAT3信号活化在川崎病Th17/Tr细胞失衡中的作用[J]. 中华微生物学和免疫学杂志, 2011, 31(6): 517-522. https://doi.org/10.3760/cma.j.issn.0254-5101.2011.06.011
|
[34]
|
Franco, A., Touma, R., Song, Y., et al. (2014) Specificity of Regulatory T Cells That Modulate Vascular Inflammation. Autoimmunity, 47, 95-104. https://doi.org/10.3109/08916934.2013.860524
|
[35]
|
郑佳. IL-6/STAT3、IL-2/STAT5信号通路在儿童过敏性紫癜Th17/Treg细胞失衡中的作用[D]: [硕士学位论文]. 泸州: 西南医科大学, 2015.
|
[36]
|
谢梦晓. IL-6和TNF-α经NF-κB-miR-34a/miR-31-Foxp3信号轴导致Treg/Th17细胞失衡[D]: [硕士学位论文]. 镇江: 江苏大学, 2016.
|
[37]
|
Raugh, A., Allard, D. and Bettini, M. (2022) Nature vs. Nurture: FOXP3, Genetics, and Tissue Environment Shape Treg Function. Frontiers in Immunology, 13, Article ID: 911151. https://doi.org/10.3389/fimmu.2022.911151
|
[38]
|
洪泽, 孙兴珍, 程学英. 肿瘤坏死因子-α和N末端脑利钠肽在川崎病患儿中的变化及临床意义[J]. 儿科药学杂志, 2016, 22(6): 29-31. https://doi.org/10.13407/j.cnki.jpp.1672-108X.2016.06.010
|
[39]
|
路振, 张玉玲. 小儿川崎病发病机制及临床诊治的研究进展[J]. 医学综述, 2021, 27(10): 1982-1987.
|
[40]
|
黄昌美, 窦常胜. 急性期川崎病患儿外周血NF-κBp65、MMP-9表达变化及意义[J]. 湘南学院学报(医学版), 2023, 25(1): 21-24. https://doi.org/10.16500/j.cnki.1673-498x.2023.01.004
|
[41]
|
Takahashi, K., Oharaseki, T. and Yokouchi, Y. (2014) Update on Etio and Immunopathogenesis of Kawasaki Disease. Current Opinion in Rheumatology, 26, 31-36. https://doi.org/10.1097/BOR.0000000000000010
|
[42]
|
孙文娟, 孙永红. NF-κB信号通路在儿童川崎病心脏损伤中的研究进展[J]. 中国当代儿科杂志, 2023, 25(3): 250-252.
|
[43]
|
Marchesi, A., Tarissi de Jacobis, I., Rigante, D., et al. (2018) Kawasaki Disease: Guidelines of the Italian Society of Pediatrics, Part I—Definition, Epidemiology, Eti-opathogenesis, Clinical Expression and Management of the Acute Phase. Italian Journal of Pediatrics, 44, Article No. 102. https://doi.org/10.1186/s13052-018-0536-3
|
[44]
|
Rabinowitz, E.J., Rubin, L.G., Desai, K., et al. (2019) Ex-amining the Utility of Coronary Artery Lack of Tapering and Perivascular Brightness in Incomplete Kawasaki Disease. Pediatric Cardiology, 40, 147-153.
https://doi.org/10.1007/s00246-018-1971-z
|
[45]
|
王慧, 张燕平, 王志强, 等. 基于孟德尔随机化探索肠道菌群与儿童川崎病之间的因果关系[J]. 心血管病学进展, 2023, 44(6): 572-576. https://doi.org/10.16806/j.cnki.issn.1004-3934.2023.06.020
|
[46]
|
Burns, J.C., Roberts, S.C., Tremoulet, A.H., et al. (2021) Infliximab versus Second Intravenous Immunoglobulin for Treatment of Resistant Kawasaki Disease in the USA (KIDCARE): A Randomised, Multicentre Comparative Effectiveness Trial. The Lancet Child & Adolescent Health, 5, 852-861. https://doi.org/10.1016/S2352-4642(21)00270-4
|
[47]
|
Kato, H., Koike, S. and Yokoyama, T. (1979) Ka-wasaki Disease: Effect of Treatment on Coronary Artery Involvement. Pediatrics, 63, 175-179. https://doi.org/10.1542/peds.63.2.175
|
[48]
|
Ogata, S., Bando, Y., Kimura, S., et al. (2009) The Strategy of Immune Globulin Resistant Kawasaki Disease: A Comparative Study of Additional Immune Globulin and Steroid Pulse Therapy. Journal of Cardiology, 53, 15-19.
https://doi.org/10.1016/j.jjcc.2008.08.002
|
[49]
|
Lim, Y.J. and Jung, J.W. (2014) Clinical Outcomes of Initial Dexa-methasone Treatment Combined with a Single High Dose of Intravenous Immunoglobulin for Primary Treatment of Ka-wasaki Disease. Yonsei Medical Journal, 55, 1260-1266. https://doi.org/10.3349/ymj.2014.55.5.1260
|
[50]
|
Ogata, S., Ogihara, Y., Honda, T., et al. (2012) Corticosteroid Pulse Combination Therapy for Refractory Kawasaki Disease: A Randomized Trial. Pediatrics, 129, e17-e23. https://doi.org/10.1542/peds.2011-0148
|
[51]
|
Shimizu, C., Eleftherohorinou, H., Wright, V.J., et al. (2016) Genetic Variation in the SLC8A1 Calcium Signaling Pathway Is Asso-ciated with Susceptibility to Kawasaki Disease and Coronary Artery Abnormalities. Circulation: Cardiovascular Genet-ics, 9, 559-568. https://doi.org/10.1161/CIRCGENETICS.116.001533
|
[52]
|
Tremoulet, A.H., Pancoast, P., Franco, A., et al. (2012) Calcineurin Inhibitor Treatment of Intravenous Immunoglobulin-Resistant Kawasaki Disease. The Jour-nal of Pediatrics, 161, 506-512.e501.
https://doi.org/10.1016/j.jpeds.2012.02.048
|
[53]
|
Shafferman, A., Birmingham, J.D. and Cron, R.Q. (2014) High Dose Anakinra for Treatment of Severe Neonatal Kawasaki Disease: A Case Report. Pediatric Rheumatology Online Journal, 12, Article No. 26.
https://doi.org/10.1186/1546-0096-12-26
|
[54]
|
Wallace, C.A., French, J.W., Kahn, S.J., et al. (2000) Initial Intra-venous Gammaglobulin Treatment Failure in Kawasaki Disease. Pediatrics, 105, E78. https://doi.org/10.1542/peds.105.6.e78
|
[55]
|
Hokosaki, T., Mori, M., Nishizawa, T., et al. (2012) Long-Term Effi-cacy of Plasma Exchange Treatment for Refractory Kawasaki Disease. Pediatrics International, 54, 99-103. https://doi.org/10.1111/j.1442-200X.2011.03487.x
|